Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials
Deucravacitinib治疗中重度斑块状银屑病长达3年的安全性和有效性:一项随机临床试验的开放标签扩展研究
期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2024.4688
Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Imafuku, Shinichi; Ohtsuki, Mamitaro; Spelman, Lynda; Passeron, Thierry; Papp, Kim A; Kisa, Renata M; Vaile, John; Berger, Victoria; Vritzali, Eleni; Hoyt, Kim; Colombo, Matthew J; Scotto, Julie; Banerjee, Subhashis; Strober, Bruce; Thaçi, Diamant; Blauvelt, Andrew